Clinical assessment of asthma severity partially corresponds to sputum eosinophilic airway inflammation

Respiratory Medicine

Volumn 98, Issue 2, 2004, Pages 184-193

  Bartoli, M L ^a   Bacci, E ^a   Carnevali, S ^a   Cianchetti, S ^a   Dente, F L ^a   Di Franco, A ^a   Giannini, D ^a   Taccola, M ^a   Vagaggini, B ^a   Paggiaro, P L ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Asthma severity; ECP; Eosinophils; Induced sputum

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; EOSINOPHIL CATIONIC PROTEIN;

ADULT; ARTICLE; ASTHMA; CELL COUNT; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CONTROL; DISEASE SEVERITY; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; FREQUENCY ANALYSIS; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; PROTEIN ANALYSIS; RESPIRATORY TRACT INFLAMMATION; SPUTUM ANALYSIS;

EID: 10744224393     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2003.09.012     Document Type: Article

References (27)

1. Mackay IR, Rosen FS. Asthma. N Engl J Med 2001;344: 350-62.
2. Wong HH, Fahy JV. Safety of one method of sputum induction in asthmatic subjects. Am J Respir Crit Care Med 1997;155:299-303.
3. Pizzichini E, Pizzichini MMM, Efthimiadis A, Evans S, Morris MM, Squillace D, Gleich GJ, Dolovich J, Hargreave FE. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurement. Am J Respir Crit Care Med 1996;154:308-17.
4. Bacci E, Cianchetti S, Carnevali S, Bartoli ML, Dente FL, Di Franco A, Giannini D, Vagaggini B, Paggiaro PL. Induced sputum is a reproducible method to assess airway inflammation in asthma. Mediat Inflamm 2002;11:293-8.
5. National Institutes of Health. Global strategy for asthma management and prevention. NIH publication No. 02-3659, February 2002.
6. Crimi E, Spanevello A, Neri M, Ind PW, Rossi GA, Brusasco V. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med 1998;157:4-9.
7. Rosi E, Ronchi MC, Grazzini M, Duranti R, Scano G. Sputum analysis, bronchial hyperresponsiveness, and airway function in asthma: results of a factor analysis. J Allergy Clin Immunol 1999;103:232-7.
8. Fujimoto K, Kubo K, Matsuzawa Y, Sekiguchi M. Eosinophil cationic protein levels in induced sputum correlate with the severity of bronchial asthma. Chest 1997;112:1241-7.
9. Ronchi MC, Piragino C, Rosi E, Stendardi L, Tanini A, Galli G, Duranti R, Scano G. Do sputum eosinophils and ECP relate to the severity of asthma? Eur Respir J 1997;10: 1809-13.
10. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999;160:1532-9.
11. Louis R, Lau CKL, Bron AO, Roldaan AC, Rademecker M, Djukanovic R. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med 2000;161:9-16.
12. Paoletti P, Pistelli G, Fazzi P, et al. Reference values for vital capacity and flow-volume curves from a general population study. Bull Eur Physiopathol Respir 1986;22:451-9.
13. Paggiaro PL, Dente FL, Morelli MC, Bancalari L, Di Franco A, Giannini D, Vagaggini B, Bacci E, Fabbri LM, Giuntini C. Postallergen inhaled budesonide reduces late asthmatic response and inhibits the associated increase of airway responsiveness to methacoline in asthmatics. Am J Respir Crit Care Med 1994;149:1447-51.
14. Bacci E, Cianchetti S, Paggiaro PL, Carnevali S, Bancalari L, Dente FL, Di Franco A, Giannini D, Vagaggini B, Giuntini C. Comparison between hypertonic and isotonic saline-induced sputum in the evaluation of airway inflammation in subjects with moderate asthma. Clin Exp Allergy 1997;26: 1395-400.
15. Wardlaw AJ, Brightling C, Green R, Woltmann G, Pavord I. Eosinophils in asthma and other allergic diseases. Br Med Bull 2000;56:985-1003.
16. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, Venge P, Ahlstedt S, Simony-Lafontaine J, Godard P, Michle FB. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-9.
17. Bradley LB, Azzawi M, Jacobson M, Assoufi B, Collins JV, Irani AMA, Schwartz LB, Durham SR, Jeffery PK, Kay AB. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol 1991;88:661-74.
18. Iredale MJ, Wanklyn SA, Phillips IP, Krausz T, Ind PW. Non invasive assessment of bronchial inflammation in asthma: no correlation between eosinophilia of induced sputum and bronchial responsiveness to inhaled hypertonic saline. Clin Exp Allergy 1994;24:940-5.
19. Laviolette M, Malmstrom K, Lu S, Chervinsky P, Pujet JC, Peszek I, Zhang J, Reiss TF, and the Montelukast/Beclomethasone Additivity Group. Montelukast added to inhaled beclomethasone in treatment of asthma. Am J Respir Crit Care Med 1999;160: 1862-8.
20. Bacci E, Di Franco A, Bartoli ML, Carnevali S, Cianchetti S, Dente FL, Giannini D, Vagaggini B, Ruocco L, Paggiaro PL. Comparison of antiinflammatory and clinical effects of beclomethasone dipropionate and salmeterol in moderate asthma. Eur Respir J 2002;20:66-72.
21. Wenzel SE, Szefler SJ, Leung DYM, Sloan SI, Rex MD, Martin RJ. Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med 1997;156:737-43.
22. Chung KF, Stirling RG, Chanez P, Godard P. Severe therapy resistant asthma. In: Chung F, Fabbri LM, editors. Asthma, ERS Monographs no, 23, Leeds, UK, January 2003. p. 312-38.
23. Sont JK, Willems LNA, Bel EH, van Krieken JHJM, Vandenbroucke JP, Sterk PJ, the AMPUL study group. Clinical control and hystopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long term treatment. Am J Respir Crit Care Med 1999;159: 1043-51.
24. Green RH, Brightling CE, McKenna S, Hargardon B, Parker D, Bradding P, Waldlaw AJ, Pavord ID. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002;360:1715-21.
25. Louis R, Sele J, Henket M, Cataldo D, Bettiol J, Seiden L, Bartsch P. Sputum eosinophil count in a large population of patients with mild to moderate steroid-naive asthma: distribution and relationship with methacoline bronchial hyperresponsiveness. Allergy 2002;57:907-12.
26. Leuppi JD, Salome CM, Jenkins CR, Koskela H, Brannan JD, Anderson SD, Andersson M, Chan HK, Woolcock AJ. Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma. Eur Respir J 2001;18:444-50.
27. Woodruff PG, Khashayar R, Lazarus SC, Janson S, Avila P, Boushey HA, Segal M, Fahy JV. Relationship between airway inflammation, hyperresponsiveness, and obstruction in asthma. J Allergy Clin Immunol 2001;108:753-8.